Prognostic impact of serum C-reactive protein in metastatic clear-cell renal cell carcinoma patients treated with nivolumab

by E. Roussel, L. Kinget, A. Verbiest, M. Albersen, B. Beuselinck
Published 2020-11-01

Molecular subtypes of fully resected clear cell renal cell carcinoma are prognostic for risk of relapse and may impact adjuvant treatment

by E. Roussel, A. Verbiest, J. Zucman-Rossi, G. Couchy, S. Caruso, L. De Wever, M. Baldewijns, S. Joniau, M. Albersen, B. Beuselinck
Published 2020-11-01

The role of cytoreductive nephrectomy in the contemporary management of metastatic kidney cancer: Predictive factors for surgical complications and oncological survival

by E. Roussel, A. Verbiest, U. Milenkovic, W. Everaerts, B. Van Cleynenbreugel, H. Van Poppel, S. Joniau, B. Beuselinck, G. Devos, T. Muilwijk, M. Albersen
Published 2020-07-01

Real-world clinical effectiveness of second-line sunitinib following immuno-oncology therapy in patients with metastatic renal cell carcinoma

by J.C. Wells, S. Dudani, C.L. Gan, I. Stukalin, A. Azad, E. Liow, F. Donskov, T. Yuasa, S. Pal, G. De Velasco, L. Wood, A. Hansen, B. Beuselinck, C. Kollmannsberger, T. Powles, B. Mcgregor, M.S. Duh, L. Huynh, D.Y.C. Heng
Published 2020-07-01

Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis

by P. Schöffski, I. Timmermans, D. Hompes, M. Stas, F. Sinnaeve, P. De Leyn, W. Coosemans, D. Van Raemdonck, E. Hauben, R. Sciot, P. Clement, O. Bechter, B. Beuselinck, F. J. S. H. Woei-A-Jin, H. Dumez, P. Nafteux, T. Wessels
Published 2020-01-01

Corrigendum to “Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis”

by P. Schöffski, I. Timmermans, D. Hompes, M. Stas, Veerle Boecxstaens, F. Sinnaeve, P. De Leyn, W. Coosemans, D. Van Raemdonck, E. Hauben, R. Sciot, P. Clement, O. Bechter, B. Beuselinck, F. J. S. H. Woei-A-Jin, H. Dumez, P. Nafteux, T. Wessels
Published 2021-01-01